Skip to main content
Year archive

Ensol Biosciences Inc. — 2026 filings

All 14 regulatory filings released by Ensol Biosciences Inc. (140610) in 2026, sourced directly from the official regulator.

14 Filings
2026 Period
2026 filings (14)
Filing Released Lang
기업설명회(IR)개최
Investor Presentation
2026-04-29 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2026-03-26 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2026-03-26 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2026-03-26 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2026-03-19 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2026-03-19 Korean
사업보고서 (2025.12)
Annual Report FY 2025
2026-03-18 Korean
감사보고서제출
Audit Report / Information FY 2025
2026-03-18 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2026-03-11 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2026-03-10 Korean
[기재정정]주요사항보고서(타법인주식및출자증권양수결정)
Regulatory Filings
2026-03-06 Korean
주요사항보고서(타법인주식및출자증권양수결정)
Regulatory Filings
2026-03-05 Korean
기타주요경영사항(자율공시)
Capital/Financing Update
2026-03-05 Korean
임상시험단계진입ㆍ종료(자율공시)
Regulatory Filings
2026-01-23 Korean